Emerald Advisers, LLC Bausch & Lomb Corp Transaction History

Emerald Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$13.68 - $17.6 $3,967 - $5,104	290 Added 1.7%	17,372 $300,000
Q4 2023 Feb 05, 2024	BUY	$14.87 - $17.56 $84,193 - $99,424	5,662 Added 49.58%	17,082 $291,000
Q3 2023 Oct 26, 2023	SELL	$16.8 - $20.99 $4,267 - $5,331	-254 Reduced 2.18%	11,420 $193,000
Q2 2023 Jul 25, 2023	SELL	$16.03 - $20.07 $2,821 - $3,532	-176 Reduced 1.49%	11,674 $234,000
Q1 2023 May 04, 2023	BUY	$15.67 - $18.91 $185,689 - $224,083	11,850 New	11,850 $206,000

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.